Showing results (31-40 of 439) with videos related to
Sort By:
Pageof 44
Seminars in Cancer Biology|August 1, 1991
On the origins of clinical drug resistanceJ P O'Brien, C Cordon-CardoBritish Journal of Cancer|December 17, 2003
Applications of array technology: identification of molecular targets in bladder cancerM Sánchez-Carbayo, C Cordon-CardoSeminars in Diagnostic Pathology|May 1, 1997
Alterations of tumor suppressor genes in bladder cancerC Cordon-Cardo, V E ReuterThe American Journal of Pathology|March 1, 1994
Expression of the retinoblastoma protein is regulated in normal human tissuesC Cordon-Cardo, V M RichonThe American Journal of Surgical Pathology|October 1, 1994
Clinical and pathobiological effects of neoadjuvant total androgen ablation therapy on clinically localized prostatic adenocarcinomaO A Armas, A G Aprikian, J Melamed, et al.Journal of the National Cancer Institute|January 6, 1993
Nuclear overexpression of p53 protein in transitional cell bladder carcinoma: a marker for disease progressionA S Sarkis, G Dalbagni, C Cordon-Cardo, et al.Seminars in Surgical Oncology|September 1, 1997
Genetic studies and molecular markers of bladder cancerC Cordon-Cardo, J Sheinfeld, G DalbagniClinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 17, 1998
Evaluation of the telomeric repeat amplification protocol (TRAP) assay for telomerase as a diagnostic modality in recurrent bladder cancerG Dalbagni, W Han, Z F Zhang, et al.Scandinavian Journal of Urology and Nephrology. Supplementum|January 6, 2001
Genetic and molecular markers of urothelial premalignancy and malignancyC Cordon-Cardo, R J Cote, G SauterProceedings of the National Academy of Sciences of the United States of America|April 1, 1981
Growth of a pure population of mouse mast cells in vitro with conditioned medium derived from concanavalin A-stimulated splenocytesE Razin, C Cordon-Cardo, R A GoodPageof 44